Airing Treatment Advances in Breast Cancer in New York

Podcast

We traveled to Long Island, New York, for a State of the Science Summit™ on Breast Cancer, which featured insights from the NYU Langone’s Perlmutter Cancer Center faculty.

We recently traveled to Long Island, New York, for an OncLive® State of the Science Summit™ on Breast Cancer. At the meeting, faculty from NYU Langone’s Perlmutter Cancer Center shed light on how to balance genomic and clinical risk in hormone receptor­—positive disease, novel approaches that are pushing the envelope in HER2-positive disease, and how tumor biology is being used to personalize surgical interventions. Other topics included exciting therapies that are propelling progress in the treatment of HR-positive, HER2-negative disease and how the paradigm for triple-negative disease is evolving with the emergence of antibody-drug conjugates, PARP inhibitors, and immunotherapy.

Related Videos
Michelle Krogsgaard, PhD
Marc J. Braunstein, MD, PhD
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine
Joshua K. Sabari, MD, an expert on lung cancer, presenting slides
Joshua K. Sabari, MD
Jeffrey S. Weber, MD, PhD
Nina D'Abreo, MD
Nina D'Abreo, MD
Yelena Novik, MD